LivaNova
Vendor Review for Medicaid Vendor Partner Readiness
- Basic Info
- EVALUATION
Overall Assessment
Summary
DME company based in England but working to increase footprint in US government funded healthcare. Focuses on cardiac surgery (heart-lung machines) and neuromodulation (vagus nerve stimulation). Will find US based employees under LivaNova, LivaNova Cares and Sorin Group. VNS device initially received mixed reviews from CMS, but may be promising treatment for depression. Now CMS covers VNS for depression nationally (in Medicare program) as part of an approved trial aimed at developing evidence to be used in coverage decisions, reversing a previous non-coverage decision.
Limited experience with Medicaid programs, but expect to be engaged by them as coverage efforts advance.
Relevant Leadership Experience
Points Possible: 212
Points Earned: 30

click to enlarge
Analyst Notes
Extensive healthcare experience
Limited Medicare and Medicaid experience
Role | | |
---|---|---|
President & CEO | ![]() Damien McDonald | Click for Bio (self-reported) |
President | ![]() Paul Buckman | Click for Bio (self-reported) |
Operations | ![]() Ryan Miller | Click for Bio (self-reported) |
Cell | ![]() Sven Ukatz | Click for Bio (self-reported) |
Cell | ![]() John Murphy | Click for Bio (self-reported) |
Cell |
![]() Sai Yedavelli |
Click for Bio (self-reported) |
Cell |
![]() Thad Huston |
Click for Bio (self-reported) |
Cell |
![]() Douglas Manko |
Click for Bio (self-reported) |
Product/Services |
![]() Bryan Olin |
Click for Bio (self-reported) |
Cell |
Cell |
Cell |
Brand Perception
Points possible: 95
Points earned: 20

click to enlarge
Analyst Notes
2 lawsuits identified
Healthy/stable culture based on internal reviews
High brand visibility
Clarity of Value Proposition
Points possible: 60
Points earned: 50

click to enlarge
Analyst Notes
Rate high on all items except use of buzzwords and non-specific language
Scalability
Points possible: 50
Points earned: 50

click to enlarge
Analyst Notes
High annual revenue
Both operations and product teams rated high experience and high tenure
16% 2 year staffin increase
Funding Model
Publicly traded- NASDAQ: LIVN
--END OF REPORT--